Company news
Suzhou Nanomicro Technology Co. Ltd. Class A (SSE:688690) news
Suzhou Nanomicro Technology Co. Ltd. Class A news releases on 6ix. Latest, Sep 22, 2026: "SUZHOU NANOMICRO TECHNOLOGY CO., LTD."Announcement on Acceptance…
Press releases & updates
"SUZHOU NANOMICRO TECHNOLOGY CO., LTD."Announcement on Acceptance by Shanghai Stock Exchange of Application for Private Placement of A-Shares
September 21, 2026
"SUZHOU NANOMICRO TECHNOLOGY CO., LTD."Announcement on Unfreezing of Frozen Shares Held by the Actual Controller
September 18, 2026
"SUZHOU NANOMICRO TECHNOLOGY CO., LTD."Announcement on Conducting Foreign Exchange Hedging Business
September 11, 2026
"SUZHOU NANOMICRO TECHNOLOGY CO., LTD."Announcement on Participating in the 2026 Semi-annual Collective Performance Briefing for the STAR Market Biological Products and CXO Industry
September 7, 2026
"SUZHOU NANOMICRO TECHNOLOGY CO., LTD."Announcement on the Shareholding Reduction Plan of the Shareholder
August 28, 2026
"SUZHOU NANOMICRO TECHNOLOGY CO., LTD."Announcement on Grant of Property Interests in the Employee Stock Ownership Plan Platform to Participants
August 26, 2026
"SUZHOU NANOMICRO TECHNOLOGY CO., LTD."Announcement on Change of Sponsor Institution and Sponsor Representatives
August 18, 2026
"SUZHOU NANOMICRO TECHNOLOGY CO., LTD."Announcement on Voluntary Disclosure of Semi-annual Performance Forecast for 2026
July 8, 2026
"SUZHOU NANOMICRO TECHNOLOGY CO., LTD."Announcement on Hosting the 2026 Investor Open Day Event
July 3, 2026
Announcement on Implementation of Dividend Distribution for 2025
May 27, 2026
Announcement on Result of the Second-Instance Judgment in the Lawsuit
May 21, 2026
Announcement on Convening the 2025 Annual and Q1 2026 Chinese-English Performance Briefing
May 13, 2026
Announcement on Resolutions of the 2025 Annual General Meeting
May 8, 2026
Report for Q1 2026
April 27, 2026
Announcement on Confirming the Implementation of Daily Related Party Transactions in 2025 and Estimated Daily Related Party Transactions in 2026
April 15, 2026
Announcement on Voluntary Disclosure of Earnings Preannouncement for Q1 2026
April 9, 2026
Announcement on the Completion of Stock Transfer under the 2026 Employee Stock Ownership Scheme
March 10, 2026
Announcement on Resolutions of the 1st Holders' Meeting for 2026 Employee Stock Ownership Plan
March 9, 2026
Announcement on Preliminary Earnings Estimate for 2025
February 26, 2026
Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026
February 12, 2026
Announcement on Resolutions of the 1st Employee Representative Meeting in 2026
January 26, 2026
Announcement on Voluntary Disclosure of Earnings Preannouncement for 2025
January 15, 2026
Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2025
December 26, 2025
Announcement on Equity Change of Shareholders with Over 5% Shares Reaching 1% Scale and Results of Shareholding Reduction
December 19, 2025
Announcement on the Gratuitous Donation of Part of the Company's Shares by the Shareholder
December 15, 2025
Notice on Convening the 2nd Extraordinary General Meeting in 2025
December 10, 2025
Announcement on Resolutions of the 1st Extraordinary General Meeting in 2025
November 17, 2025
Announcement on Cancellation of Some Proposals at the 1st Extraordinary General Meeting in 2025
November 11, 2025
Announcement on Convening the Q3 2025 Performance Briefing
October 28, 2025
Indicative Announcement on Changes in Equity of Shareholders holding More Than 5% of Shares Reducing Their Holdings to Below 5%
September 29, 2025
Announcement on Convening Semi-annual Collective Performance Briefing for SSE STAR Market Enterprises in Biological Products and CXO Industries in 2025
September 5, 2025
Announcement on Shareholding Reduction Plan for Shareholders
August 29, 2025
Announcement on Making Provisions for Asset Impairment for the Half-Year Period of 2025
August 27, 2025
Announcement on Result of Shareholding Reduction by Shareholder
August 12, 2025
Indicative Announcement on Change in Equity of Shareholders with Over 5% Shares Reaching 1% Scale
July 31, 2025
Announcement on 2025 Interim Voluntary Disclosure of Earnings Preannouncement
July 9, 2025
Announcement on Closing Some Investment Projects Financed by Raised Funds, Using Residual Raised Funds to Permanently Supplement Current Capital and Postponing Some Investment Projects Financed by Raised Funds
July 1, 2025
Announcement on Implementation of Dividend Distribution for 2024
June 6, 2025
Announcement on Resolution of the 2024 Annual General Meeting
May 15, 2025
Announcement on Share Reduction Plan for Shareholders
May 12, 2025
Announcement on Attending the Annual Collective Performance Briefing for Innovative Drug Companies on SSE STAR Market 2024 and the Q1 2025 Performance Briefing
April 27, 2025
Notice on Convening the 2024 Annual General Meeting
April 24, 2025
Announcement on Progress in Litigation Involved
April 21, 2025
Announcement on Preliminary Earnings Estimate for 2024
February 26, 2025
Announcement on the Implementation Results of Share Repurchase and Changes in Shares
January 27, 2025
Announcement on Resignation of Senior Management Member
January 14, 2025
Announcement on Progress in Repurchasing Shares through Call Auction
January 2, 2025
Announcement on Results of Shareholding Reduction by Shareholders
December 24, 2024
Announcement on Proposed Establishment of Subsidiary and Purchase of Land Use Right
December 20, 2024
Announcement on Progress of Shareholding Reduction by Shareholders
December 17, 2024